Maria Gonzalez-Rellan and our collaborators, Cristina Riobello Surez Marta Varela Reyproviding further evidence for the importance of Liver Sinusoidal Endothelial Cell-Stellate Cell communication in metabolic liver disease, now with a GLP-1 receptor dimension Cell Metabolism by Cell Press Lunenfeld-Tanenbaum Research Institute, Sinai HealthTemerty Faculty of Medicine, University of Toronto Banting & Best Diabetes Centre Important shift in understanding this moves Semaglutide beyond weight loss into targeted liver biology
Glp-1 receptor agonists (Glp-1ras): Cardiovascular actions and therapeutic potential
This dysregulated metabolism creates an environment characterized by persistent oxidative stress, chronic inflammation, and altered energy signaling, which collectively drive fibrosis and cellular transformation (Ramaite and Nkadimeng, 2025)
GLP-1 drugs may help by: Supporting weight loss Improving blood sugar control Lowering appetite and calorie intake Reducing strain linked with Excess body weight Improving some cardiometabolic markers Possibly affecting inflammation pathways Supporting better long-term risk management However, no patient should see these medicines as a quick fix
Regor Therapeutics Group Chugai Pharmaceutical Co., Ltd
This assay is a Sandwich ELISA based, sequentially, on: 1) capture of GLP-1 Total molecules from samples to the wells of a microtiter plate coated by a pre-titered amount of anti- GLP-1 polyclonal antibody, 2) wash away of unbound materials from samples, 3) binding of a biotinylated anti- GLP-1 monoclonal antibody to the captured molecules, 4) wash away of unbound materials from samples, 5) conjugation of horseradish peroxidase to the immobilized biotinylated antibodies, 6) wash away of free enzyme conjugates, and 7) quantification of immobilized antibody-enzyme conjugates by monitoring horseradish peroxidase activities in the presence of the substrate 3,3,5,5-tetramethylbenzidine
